Objective Evasluate the adenosine triphosphate tumor chemosensitivity assay(ATP-TCA) in guiding clinical chemotherapy for non-small-cell lung cancer(NSCLC) patients.

• 目的研究肺癌体外化疗药物敏感性与临床疗效的关系,为临床化疗方案的个体化选择提供依据。